ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag techniques science policy funding ethics

Pain Researcher Quits Academia, Takes Lab Home with Him
Jef Akst | May 1, 2021 | 6 min read
After resigning from the University of New England last year, Geoffrey Bove continues to study the effects of massage on rats in a facility he set up in his house.
Fixing the Flaws in Animal Research
Diana Kwon | Sep 1, 2019 | 8 min read
Many preclinical studies carried out in vivo are poorly designed and generate irreproducible data, but efforts to address the problem are on the rise.
japan flag chimera animal research
Bioethicists Concerned over Japan’s Chimera Embryo Regulations
Katarina Zimmer | Apr 4, 2019 | 5 min read
Many researchers see the move to relax the rules as a welcome change, yet some are worried the revisions don’t take public concerns enough into consideration.
Cultivating Policy from Cell Types
Eugene Russo | May 27, 2001 | 7 min read
For better or worse, stem cell science has become inextricably married to stem cell politics. Policymakers who oppose public financing of embryonic stem cells have used recent adult stem cell findings to argue for a dismissal of the NIH stem cell guidelines (see "On the Brink," page 1). The guidelines, finalized last summer during the Clinton administration, call for funding the use, but not derivation, of human embryonic stem cells (ESCs); the pro-life Bush administration appears ready to ban t
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
DID HARVARD ABANDON 'ETHIC' FOR DOLLARS?
The Scientist Staff | Dec 11, 1988 | 3 min read
As university after university joined the patent chase, one academic institution stood out as a bulwark of ethical resolve—that is, until now. The university was Harvard, and even though the school began licensing inventions more than a decade ago, it earned its reputation as a bastion of purity because of landmark decision in 1981. At issue then was a controversial proposal involving molecular biologist Mark Ptashne, whose advances in recombinant DNA techniques were giving rise to new t
Facing Ethical Dilemmas: Scientists Must Lead The Charge
Tom Hoshiko | Oct 27, 1991 | 9 min read
Recent revelations of scientific misconduct and fraud have brought into question the claim of the science community to self-regulation. Treatises on research fraud and problems in "peer review" proliferate, and even the United States Secret Service reportedly has been enlisted in the search for fraud in scientific notebooks (Science, 251:1168-72, 1991). The old assumption that fraud inevitably will be revealed seems unacceptable. The stakes have become too high to rely on traditional mechanism
NIH Lifts Stem Cell Funding Ban, Issues Guidelines
Kate Devine | Sep 17, 2000 | 3 min read
Ever since the isolation and culturing of human pluripotent stem cells in 1998, the debate has intensified regarding legal, ethical, and social ramifications associated with research use of these cells that are capable of developing into many different specialized tissues.1, 2 In order for the National Institutes of Health to clarify its position on research with these cells, in January 1999, it placed a moratorium on use of human pluripotent stem cells derived from embryos and fetal tissue in f
The Price of DNA IDs
Jef Akst | Sep 16, 2013 | 2 min read
Following natural disasters or violent political turmoil, DNA science can help identify victims. But what if a country can’t afford the technology?
The Science Behind Stem Cell Research
Bert Vogelstein | Oct 14, 2001 | 3 min read
President Bush's recent decision to allow federal funding of limited research using embryonic stem cells followed weeks of heated debate among scientists, policymakers, medical experts, and patient advocates. At the heart of the controversy are the complicated moral and legal issues surrounding the source of these stem cells, since those that are most valuable to scientists can only be obtained from human embryos. Yet stem cells may offer unprecedented opportunities for developing new therapies

Run a Search

ADVERTISEMENT